SAMARTH LIFESCIENCES
Quadria, PE funds eye stake in Samarth Lifesciences; deal may value firm at Rs 4,500 crore
Buy in Samvat 2082. Sell in Samvat 2087: Bet on policy push & macro change. 13 stocks from 3 sectors worth holding for 5 Diwalis & Holis
Skepticism & multibaggers: 15 stocks where element of skepticism is high, need is basic & now policy direction is right
Government steps in to address shortage of life-saving D-Penicillamine drugPanacea Biotec under its brand ‘Cilamin 250’, said on Wednesday that it has made the medicine available in limited quantities in the retail...30 Sep, 2016, 09.06 AM IST
Government steps in to address shortage of life-saving drugOver the last five months, companies here have been facing difficulties with suppliers of the raw material used to make the medicine, said ...29 Sep, 2016, 10.55 PM IST
Load More